Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2281 of 6351
-
New diabetes drug shows promise in phase 2 trial
Disease control OngoingThe purpose of this study is to evaluate the glycemic control and safety of SHR-3167 and Insulin Degludec in type 2 diabetic participants treated with basal insulin with or without oral antidiabetic drugs.
Phase 2 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
New procedure offers hope for knee pain without surgery
Symptom relief Recruiting nowThe goal of this observational study (prospective registry) is to collect long-term real-world data on the effectiveness and safety of genicular artery embolization (GAE) for knee osteoarthritis in adults aged 18 years or older with symptomatic KOA that has not responded to medic…
Sponsor: Joint & Vascular Institute • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC
-
Gluten-Free diet may ease Hashimoto's symptoms, study finds
Symptom relief OngoingHashimoto's thyroiditis is an autoimmune condition that reduces functioning of the thyroid gland and can lead to a substantial decline in quality of life for patients, with impacted patients often describing unremitting brain fog, fatigue/malaise and weight gain leading to diffic…
Sponsor: The Cleveland Clinic • Aim: Symptom relief
Last updated Jun 27, 2026 12:30 UTC
-
Could your genes raise your risk of heart muscle inflammation?
Knowledge-focused OngoingThe aim of this retrospective, non-interventional study is to assess the prevalence and describe the genetic variants found in a cohort of patients with acute myocarditis confirmed by MRI. This is a study linked to the MyocarditIRM cohort, designed to collect genetic test results…
Sponsor: French Cardiology Society • Aim: Knowledge-focused
Last updated Jul 23, 2026 00:00 UTC
-
Can diabetes and heart drugs help failing right hearts? new trial launches
Disease control Recruiting nowThe primary objective of the CRAVE feasibility trial is to assess the feasibility of conducting a larger CRAVE platform trial by performing a randomized trial of 30 participants with pulmonary hypertension and right ventricular dysfunction, comparing empagliflozin or ranolazine p…
Phase 2 • Sponsor: University of Alberta • Aim: Disease control
Last updated Jun 26, 2026 17:43 UTC
-
Allergy drug could tame gut inflammation in colitis
Disease control Recruiting nowUlcerative colitis (UC) is a chronic inflammatory condition that primarily targets the large intestine. Although substantial progress has been made in treatment modalities-especially with the development of immunomodulatory drugs and biologic therapies-managing UC continues to pr…
Phase 2 • Sponsor: Alexandria University • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Could a drug combo during surgery speed up recovery?
Symptom relief OngoingUp to 40% of patients experience suboptimal recovery in the days following major surgery, limiting their return to functional independence. Few preventive interventions exist, but intravenous dexmedetomidine and lidocaine administered during general anesthesia represent simple st…
Sponsor: CHU de Quebec-Universite Laval • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
Feeding into the small intestine may reduce reflux and oxygen dips in fragile preterm infants
Disease control Recruiting nowThe goal of this clinical trial is to learn if transpyloric tube feeding (feeding directly into the small intestine) versus gastric tube feeding tolerably and effectively reduces gastroesophageal reflux in infants born premature who have been diagnosed with bronchopulmonary dyspl…
Sponsor: Children's Hospital of Philadelphia • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Robotic ankle tests could sharpen stroke rehab
Knowledge-focused PausedThe purpose of this study is to capture sensorimotor ankle function in a chronic stroke population through validation of novel, experimental metrics and their comparison with established, clinical measures of function. For this purpose, the researchers will evaluate various singl…
Sponsor: Shirley Ryan AbilityLab • Aim: Knowledge-focused
Last updated Jul 16, 2026 00:00 UTC
-
Can Real-Time glucose data make diet advice more effective for diabetes?
Disease control Recruiting nowThis project will compare medical nutrition therapy personalized by continuous glucose monitor (CGM) feedback to control interventions in participants with type 2 diabetes mellitus (T2DM).
Sponsor: University of Minnesota • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
New hip resurfacing device tracked for 10 years in 150 patients
Disease control Recruiting nowThe goal of this observational study is to collect clinical and radiological data to monitor the safety and performance of the ROMAX hip resurfacing system. The main parameter that will be measured is the rate of revisions at 10 years.
Sponsor: Medacta International SA • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Could a smart patch help older diabetics ditch the finger pricks?
Disease control Recruiting nowThe goal of this clinical trial is to learn if continuous glucose monitoring system works to improve glucose control in non-insulin-treated older adults with type 2 diabetes. The main questions it aims to answer are: * Dose the use of continuous glucose monitoring system improve…
Sponsor: Shanghai 6th People's Hospital • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Blood test could spot colon cancer in second round of screening
Diagnosis Recruiting nowThe Shield post-approval study (PAS) is a prospective, longitudinal study supplemented with Real World Evidence (RWE) to evaluate the longitudinal performance of Shield in an average risk population at a second round of testing for individuals between the ages of 45 and 81 at ave…
Sponsor: Guardant Health, Inc. • Aim: Diagnosis
Last updated Aug 09, 2026 00:00 UTC
-
New schizophrenia drug tested for Long-Term safety in major trial
Disease control Recruiting nowThis study will evaluate the long-term safety of NBI-1117568 in adults with schizophrenia.
Phase 3 • Sponsor: Neurocrine Biosciences • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Smart knees may help amputees stay steady and active
Symptom relief Recruiting nowThe goal of this study is to find out if using microprocessor-controlled prosthetic knees (MPKs), prosthetic knees with a built-in computer, improves health outcomes related to falls in adults who use above-knee prostheses. The main questions are: * Do individuals with MPKs have…
Sponsor: Hanger Institute for Clinical Research and Education, LLC • Aim: Symptom relief
Last updated Jun 27, 2026 09:02 UTC
-
Can CBD calm social anxiety? MIT study seeks answers
Symptom relief Recruiting nowThe purpose of this study is to test whether a single-dose of Epidiolex (cannabidiol) is associated with reduced psychological, physiological, and neuroimaging measures of anxiety in people diagnosed with social anxiety disorder (SAD).
Phase 4 • Sponsor: Massachusetts Institute of Technology • Aim: Symptom relief
Last updated Aug 13, 2026 00:00 UTC
-
New drug safety check for Hard-to-Treat bile duct cancer
Disease control Recruiting nowThe primary purpose of this study is to investigate the safety of Tasfygo.
Sponsor: Eisai Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Could adding oxytocin speed up labor induction after a C-Section?
Disease control OngoingA randomized trial of patients undergoing a term (≥37 weeks) induction of labor with a history of one prior Cesarean delivery, wherein the provider intends to use a Foley catheter for cervical ripening. The investigators will be comparing Foley alone with concurrent Foley and Oxy…
Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Could a simpler Two-Drug HIV regimen be just as effective as three?
Disease control Recruiting nowA single-center, open-label, randomized pilot clinical trial between March 2025 and March 2026 at the Hospital de Infectología "La Raza" National Medical Center in Mexico City. Eligible participants were adult males (≥18 years) with HIV-1 infection who had maintained virological …
Phase 4 • Sponsor: Instituto Mexicano del Seguro Social • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New triple therapy takes on untreatable liver cancer
Disease control By invitation onlyThis is an open-label, single-center, single-arm phase Ib clinical trial. The aim of this study is to assess the safety and efficacy of JS014 in combination with Toripalimab and transarterial chemoembolization (TACE) for unresectable hepatocellular carcinoma (HCC). The primary en…
Phase 1 • Sponsor: Xiangya Hospital of Central South University • Aim: Disease control
Last updated Jun 26, 2026 19:07 UTC